Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prentke Romich Company, commonly branded as PRC-Saltillo, is a longstanding U.S. assistive-technology company focused on augmentative and alternative communication for people with significant speech and language impairments. The company develops and commercializes speech-generating devices, AAC software apps, vocabulary/language systems, and access technologies such as eye-gaze and head-tracking tools. Its product portfolio is used across pediatric and adult populations with conditions including autism, cerebral palsy, ALS, aphasia, and other complex communication disorders. PRC-Saltillo also provides clinical support, funding assistance, training resources, and educational content for speech-language pathologists, caregivers, schools, and rehabilitation settings. It is not a drug-development biotech company; rather, it is a commercial-stage healthcare and medical device business operating in the AAC and durable medical equipment market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prentke Romich Company.